查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球漱口水市場（按產品類型、適應症、分銷管道和地區分類）- 預測至 2030 年
市場調查報告書
商品編碼
1808085

全球漱口水市場（按產品類型、適應症、分銷管道和地區分類）- 預測至 2030 年

Oral Rinses Market by Product Type, Indication, Distribution Channel, Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 238 Pages | 訂單完成後即時交付

價格

預計全球漱口水市場規模將從 2025 年的 43 億美元成長至 2030 年的 58.9 億美元，預測期內的複合年成長率為 6.5%。

人們對先進口腔護理產品的認知度不斷提升，以及全球人口的不斷成長，預計將推動漱口水市場的成長。配方技術的持續創新，包括氟化物、精油、草本活性成分和無酒精基質的使用，正在提升產品的功效、安全性和消費者吸引力。這些改進使漱口水更加有效、便捷且更具吸引力，從而促進其在更廣泛的客戶群和臨床應用中的應用。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
單元 10億美元
部分 產品類型、適應症、通路、地區
目標區域 亞太地區、北美、拉丁美洲、中東和非洲、海灣合作理事會國家

由於牙科疾病的增加和需要額外口腔護理的老年人口的增加，需求也在成長，然而，治療性漱口水的成本高以及某些市場消費者的接受度和依從性較低，可能會限制更廣泛的市場採用。

漱口水市場-IMG1

按產品類型分類，治療性漱口水佔據全球漱口水市場的最大佔有率。

治療性漱口水憑藉其顯著的功能優勢和臨床支持，在口腔衛生市場佔據主導地位。這些配方富含活性成分，可有效降低細菌負荷，降低牙周病風險，並促進琺瑯質完整性。這些產品專為解決口腔衛生問題的病因而設計，而非僅僅是緩解症狀。牙醫的專業推薦、消費者對長期口腔健康維護的日益重視，以及對口腔健康與全身疾病之間關聯性日益成長的認知，是這些產品被廣泛採用的主要驅動力。這些產品在診所和零售店均易於獲取，進一步提升了市場滲透率。

根據適應症，一般口腔健康領域佔據全球漱口水市場的最大佔有率。

預計一般口腔健康領域將佔據最大的市場佔有率，因為其廣泛的市場定位使製造商能夠吸引多元化的消費者群體，包括重視預防性口腔護理的個人。該領域的成長要素包括更便捷的管道、有限的監管限制以及不斷提升的零售意識。此外，以品牌為中心的策略行銷措施對於將普通漱口水納入全球日常個人護理體系至關重要，從而增強了市場主導地位。該領域的需求軌跡相對穩定，使其成為長期投資策略中頗具吸引力的前景。業內主要企業始終將此類別納入其投資組合，並將其視為銷售額和市場佔有率成長的主要驅動力。

根據分銷管道，消費者商店部門佔據全球漱口水市場的最大佔有率。

消費品零售商憑藉其龐大的實體店、較高的店內品牌知名度以及日常消費者的便利性，在漱口水市場中佔據主導地位。超級市場和綜合零售商提供各式各樣的商品，方便消費者輕鬆比較品牌。此外，這些門市經常會推出促銷策略和獎勵，以刺激衝動購買行為。將口腔護理產品融入日常購物中，可顯著提升此通路的銷售量。此外，與日常消費品(FMCG)經銷商建立的合作關係以及最佳化的陳列策略，也為消費者在市場上提供了競爭優勢。

本報告對全球漱口水市場進行了分析，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 主要發現

  • 漱口水市場概覽
  • 亞太地區漱口水市場（按產品類型和國家分類）
  • 漱口水市場：地理成長機會
  • 漱口水市場：區域分佈
  • 漱口水市場：已開發市場與新興市場（2025 年及 2030 年）

第5章市場概述

  • 介紹
  • 市場動態
    • 驅動程式
    • 抑制因素
    • 機會
    • 任務
  • 產業趨勢
    • 大型製藥公司策略性剝離消費者保健部門
    • 消費者轉向潔淨標示，天然草本漱口水日益流行
  • 技術分析
    • 主要技術
    • 互補技術
    • 鄰近技術
  • 定價分析
    • 主要企業平均售價趨勢（2022-2024年）
    • 各地區漱口水平均售價趨勢（2022-2024 年）
  • 生態系分析
  • 還款情境分析
  • 價值鏈分析
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 供應鏈分析
  • 貿易分析
    • HS 編碼 330690 的進口資料（2020-2024 年）
    • HS 編碼 330690 的出口資料（2020-2024 年）
  • 監管分析
    • 法規結構
    • 監管機構、政府機構和其他組織
  • 專利分析
    • 漱口水市場專利出版趨勢
    • 司法管轄區分析：漱口水市場主要專利申請人
    • 關鍵專利清單
  • 大型會議和活動（2025-2026年）
  • 鄰近市場分析
  • 影響客戶業務的趨勢/中斷
  • 未滿足的需求/最終用戶期望
    • 未滿足的需求
    • 最終用戶的期望
  • 人工智慧/生成式人工智慧對漱口水市場的影響
  • 案例研究分析
    • CAPHOSOL漱口水有效治療化療引起的口腔黏膜炎
    • 抗菌漱口水人工呼吸器人工呼吸器相關肺炎（VAP）
    • 草本漱口水，作用類似洛赫西定，但沒有副作用
  • 投資金籌措場景
  • 2025年美國關稅對漱口水市場的影響
    • 介紹
    • 主要關稅稅率
    • 主要關稅稅率
    • 價格影響分析
    • 對國家的影響
    • 對終端產業的影響

第6章 漱口水市場（依產品種類）

  • 介紹
  • 治療性漱口水
  • 化妝品沖洗
  • 其他漱口水

第7章 漱口水市場（依適應症）

  • 介紹
  • 一般口腔健康
  • 牙齦炎和牙周病
  • 口臭
  • 口乾
  • 其他適應症

第 8 章 漱口水市場（依通路）

  • 介紹
  • 消費品商店
  • 零售藥局和牙科診所
  • 網上分銷

第9章 漱口水市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
  • 海灣合作理事會國家

第10章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 收益分析（2020-2024）
  • 市場佔有率分析（2024年）
  • 企業評估矩陣：主要企業（2024年）
  • 公司評估矩陣：Start-Ups/中小企業（2024 年）
  • 公司估值及財務指標
  • 品牌/產品比較
  • 主要企業研發支出
  • 競爭場景

第11章 公司簡介

  • 主要企業
    • KENVUE
    • COLGATE-PALMOLIVE COMPANY
    • PROCTER & GAMBLE
    • HALEON GROUP OF COMPANIES
    • UNILEVER
    • CHURCH & DWIGHT CO., INC.
    • LION CORPORATION
    • AMWAY CORP.
    • SUNSTAR SUISSE SA
    • PERRIGO COMPANY PLC
    • DABUR
    • HIMALAYA WELLNESS COMPANY
    • KAO CORPORATION
    • OPELLA HEALTHCARE GROUP SAS
    • SMARTMOUTH ORAL HEALTH LABORATORIES
  • 其他公司
    • DENTAID
    • CLOSYS
    • SCANDERRA GMBH
    • PEARLIE WHITE
    • WILD
    • BOKA
    • PERFORA
    • SALT ORAL CARE
    • ORABIO
    • LUMINEUX

第12章 附錄

Product Code: MD 9454

The global oral rinses market is projected to reach USD 5.89 billion in 2030 from USD 4.30 billion in 2025, at a CAGR of 6.5% during the forecast period.Growing awareness of advanced oral care products, along with a rising global population, is expected to drive the growth of the oral rinses market. Continuous innovation in formulation technologies, including the use of fluoride variants, essential oils, herbal actives, and alcohol-free bases, is improving product effectiveness, safety, and appeal to consumers. These improvements are increasing the effectiveness, availability, and attractiveness of oral rinses to a broader range of customers and clinical uses.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct Type, Indication, Distribution Channel, and Region
Regions coveredAsia Pacific, North America, Europe, Latin America, Middle East & Africa, and GCC Countries

Demand is also growing due to an increase in dental diseases and an aging population in need of additional oral care. However, broader market adoption may be limited by the high cost of therapeutic mouthwash and, in some markets, low consumer acceptance or adherence.

Oral Rinses Market - IMG1

By product type, the therapeutic rinses segment had the largest share of the global oral rinses market.

The global oral rinses market is divided into three main segments: therapeutic rinses, cosmetic rinses, and others. The therapeutic rinses segment dominates the oral hygiene market due to their significant functional advantages and clinical endorsement. These formulations are enriched with active agents that effectively lower bacterial loads, mitigate the risk of periodontal diseases, and promote enamel integrity. They are specifically engineered to address the etiology of oral health issues rather than merely alleviating symptoms. Key drivers for their adoption include professional recommendations from dentists, an increasing consumer emphasis on long-term oral health maintenance, and heightened awareness of the correlation between oral health and systemic conditions. The accessibility of these products in both clinical environments and retail outlets further amplifies their market penetration.

The general oral health segment commanded the largest share of the global oral rinses market based on indication.

The global oral rinses market is divided into several categories based on indication: general oral health, gingivitis & periodontal diseases, halitosis, dry mouth, and other conditions. The general oral health segment is anticipated to command the largest share of the market due to its expansive positioning, enabling manufacturers to engage a diverse consumer base, including individuals focused on preventive oral care. Contributing factors to this segment's growth include enhanced accessibility, minimal regulatory constraints, and robust retail visibility. Furthermore, strategic brand-centric marketing initiatives have been pivotal in embedding general-use mouthwashes into daily personal care regimens globally, thereby reinforcing their market dominance. This segment exhibits relatively stable demand trajectories, making it an appealing prospect for long-term investment strategies. Leading industry players have consistently prioritized this category within their portfolios, recognizing it as a principal contributor to sales volume and market share expansion.

By distribution channel, the consumer stores segment accounted for the largest share of the global oral rinses market.

The global oral rinses market is divided by distribution channel into consumer stores, retail pharmacies & dental dispensaries, and online sales. Consumer retail outlets dominate the oral rinses market, attributed to their extensive physical presence, high in-store brand visibility, and the convenience they afford to everyday shoppers. Supermarkets and general retail establishments facilitate direct access to a diverse range of products, enabling consumers to easily compare brands. Additionally, these venues frequently implement promotional strategies and incentives that stimulate impulse purchasing behaviors. The integration of oral care products into routine grocery shopping significantly boosts sales volumes through this channel. Furthermore, established collaborations with fast-moving consumer goods (FMCG) distributors and optimized shelf placement strategies enhance their competitive advantage within the market.

The Asia Pacific is expected to grow at the highest CAGR in the oral rinses market during the forecast period.

The rapid growth of the population in the Asia Pacific region, coupled with a rising demand for sophisticated oral care solutions, is significantly driving the market for oral rinses. As the middle class expands, consumer interest in maintaining oral health has surged, leading to a greater emphasis on the importance of effective oral hygiene products. In response to these trends, leading global companies in the oral care industry are strategically increasing their presence in this dynamic market. They are doing so by introducing innovative formulations that cater to diverse needs, such as whitening, sensitivity relief, and antibacterial properties, as well as launching digitally integrated oral hygiene solutions that promote seamless user experiences. Moreover, indication-specific mouthwashes designed to target particular oral health issues are becoming increasingly popular, further contributing to the robust demand for oral rinses across the region.

A breakdown of the primary participants (supply side) for the oral rinses market referred to in this report is provided below:

  • By Company Type: Tier 1 (30%), Tier 2 (35%), and Tier 3 (35%)
  • By Designation: C-level Executives (20%), Directors (35%), and Others (45%)
  • By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (20%), Middle East & Africa (2%), GCC Countries (3%)

Prominent players in the oral rinses market include Colgate-Palmolive Company (US), Kenvue (US), Procter & Gamble (US), Haleon Group of Companies (UK), Unilever (UK), Church & Dwight Co., Inc. (US), Lion Corporation (Japan), Amway (US), SUNSTAR Suisse S.A. (Switzerland), Perrigo Company plc (Ireland), Dabur (India), Himalaya Wellness Company (India), Kao Corporation (Japan), Opella Healthcare Group SAS (France), SmartMouth Oral Health Laboratories (US), Dentaid Ltd. (Spain), CloSYS (US), SCANDERRA GmbH (Switzerland), Pearlie White (Singapore), Dr. Wild & Co. AG (Switzerland), Boka (US), Perfora (India), Salt Oral Care (India), OraBio, Inc. (US), and Lumineux (US).

Research Coverage

The report offers an analysis of the oral rinses market, focusing on estimating the market size and potential for future growth across various segments, including distribution channels, regions, indications, and product types. Additionally, the report includes a competitive analysis of major market players, detailing their company profiles, product and service offerings, recent developments, and key strategies.

Reasons to Buy the Report

The report delivers critical insights for industry leaders and new entrants within the oral rinses sector, presenting estimated revenue projections for the overall market as well as its distinct segments. It facilitates a comprehensive understanding of the competitive landscape, enabling stakeholders to effectively position their businesses and devise robust go-to-market strategies. Furthermore, the document delineates key market drivers, constraints, challenges, and opportunities, equipping stakeholders to evaluate prevailing market conditions with a high degree of accuracy.

This report provides insights into the following pointers:

  • Analysis of key drivers (high incidence of dental diseases, product innovation and advanced formulations), restraints (side effects from prolonged use, competition from alternative products), opportunities (rising trend of online purchasing and e-commerce, growing awareness about oral hygiene), and challenges (limited penetration in rural areas, high price points limit broader consumer adoption).
  • Market Penetration: This report provides detailed information on the product portfolios offered by major players in the global oral rinses market. It covers various segments, including product types, indications, distribution channels, and regions.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global oral rinses market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product type, indication, distribution channel, and region.
  • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global oral rinses market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global oral rinses market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Objectives of primary research
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE SHARE ANALYSIS
    • 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
    • 2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
    • 2.2.4 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 SCOPE-RELATED LIMITATIONS
    • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ORAL RINSES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE AND COUNTRY
  • 4.3 ORAL RINSES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 ORAL RINSES MARKET: REGIONAL MIX
  • 4.5 ORAL RINSES MARKET: DEVELOPED VS. EMERGING MARKETS, 2025 VS. 2030

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High incidence of chronic dental diseases
      • 5.2.1.2 Increasing household purchasing power of middle-class population in emerging economies
      • 5.2.1.3 Rising focus on creating public awareness and targeted educational campaigns
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of therapeutic and specialty formula-based oral rinses
      • 5.2.2.2 Side effects from prolonged use of therapeutic and alcohol-based mouthwashes
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising trends of online purchasing and e-commerce
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Rising number of product recalls
      • 5.2.4.2 Limited penetration in rural and semi-urban areas in emerging economies
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 STRATEGIC DEMERGER OF CONSUMER HEALTHCARE DIVISIONS BY LEADING PHARMACEUTICAL COMPANIES
    • 5.3.2 RISE OF NATURAL AND HERBAL ORAL RINSES AMID CLEAN-LABEL CONSUMER SHIFT
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Flouride
      • 5.4.1.2 Anti-microbial agents
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Essential oils
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Electric dental flossers
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER, 2022-2024
    • 5.5.2 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022-2024
  • 5.6 ECOSYSTEM ANALYSIS
    • 5.6.1 ROLE IN ECOSYSTEM
  • 5.7 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.8 VALUE CHAIN ANALYSIS
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.9.2 BARGAINING POWER OF SUPPLIERS
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 THREAT OF SUBSTITUTES
    • 5.9.5 THREAT OF NEW ENTRANTS
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 KEY BUYING CRITERIA
  • 5.11 SUPPLY CHAIN ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 IMPORT DATA FOR HS CODE 330690, 2020-2024
    • 5.12.2 EXPORT DATA FOR HS CODE 330690, 2020-2024
  • 5.13 REGULATORY ANALYSIS
    • 5.13.1 REGULATORY FRAMEWORK
      • 5.13.1.1 North America
        • 5.13.1.1.1 US
      • 5.13.1.2 European Union
      • 5.13.1.3 Asia Pacific
        • 5.13.1.3.1 China
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PATENT ANALYSIS
    • 5.14.1 PATENT PUBLICATION TRENDS FOR ORAL RINSES MARKET
    • 5.14.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN ORAL RINSES MARKET
    • 5.14.3 LIST OF MAJOR PATENTS
  • 5.15 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.16 ADJACENT MARKET ANALYSIS
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
    • 5.18.1 UNMET NEEDS
    • 5.18.2 END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON ORAL RINSES MARKET
  • 5.20 CASE STUDY ANALYSIS
    • 5.20.1 CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE CHEMOTHERAPY-INDUCED ORAL MUCOSITIS
    • 5.20.2 ANTISPECTIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS
    • 5.20.3 HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS
  • 5.21 INVESTMENT & FUNDING SCENARIO
  • 5.22 IMPACT OF 2025 US TARIFF ON ORAL RINSES MARKET
    • 5.22.1 INTRODUCTION
    • 5.22.2 KEY TARIFF RATES
    • 5.22.3 KEY TARIFF RATES
    • 5.22.4 PRICE IMPACT ANALYSIS
    • 5.22.5 IMPACT ON COUNTRY/REGION
      • 5.22.5.1 North America
        • 5.22.5.1.1 US
      • 5.22.5.2 Europe
      • 5.22.5.3 Asia Pacific
    • 5.22.6 IMPACT ON END-USE INDUSTRIES

6 ORAL RINSES MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
  • 6.2 THERAPEUTIC RINSES
    • 6.2.1 INCREASING PREVALENCE OF ORAL DISEASES TO BOOST ADOPTION OF THERAPEUTIC RINSES
  • 6.3 COSMETIC RINSES
    • 6.3.1 RISE IN AESTHETIC CONSCIOUSNESS TO PROMOTE ADOPTION OF COSMETIC RINSES
  • 6.4 OTHER RINSES

7 ORAL RINSES MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 GENERAL ORAL HEALTH
    • 7.2.1 GENERAL USE MOUTHWASHES TO REDUCE PLAQUE, FRESHEN BREATH, SUPPORT GUM HEALTH, AND ENHANCE ORAL CLEANLINESS
  • 7.3 GINGIVITIS & PERIODONTAL DISEASES
    • 7.3.1 WIDESPREAD PREVALENCE OF GUM-RELATED CONDITIONS AND HIGH DEMAND FOR NON-INVASIVE TREATMENTS TO DRIVE MARKET
  • 7.4 HALITOSIS
    • 7.4.1 RISING AESTHETIC CONSCIOUSNESS TO FUEL ADOPTION OF ORAL RINSES FOR BAD BREATH
  • 7.5 DRY MOUTH
    • 7.5.1 RISING GERIATRIC POPULATION WITH CHRONIC DISEASES TO PROPEL SEGMENT GROWTH
  • 7.6 OTHER INDICATIONS

8 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 INTRODUCTION
  • 8.2 CONSUMER STORES
    • 8.2.1 BROAD ACCESSIBILITY, IN-STORE MARKETING, AND SEASONAL PROMOTIONS TO INCREASE SALES IN CONSUMER STORE
  • 8.3 RETAIL PHARMACIES & DENTAL DISPENSARIES
    • 8.3.1 STRONG CLINICAL ENDORSEMENT AND INCREASED CONSUMER TRUST TO FUEL SALES OF ORAL RINSES
  • 8.4 ONLINE DISTRIBUTION
    • 8.4.1 RISE IN INTERNET USE, EVOLVED DIGITAL SHOPPING HABITS, AND CONVENIENCE OF DIRECT-TO-DOOR DELIVERY TO DRIVE MARKET

9 ORAL RINSES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American oral rinses market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 Better network of dental professionals and robust healthcare infrastructure to propel market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 High prevalence of edentulism and willingness to invest in advanced personal care products to augment market growth
    • 9.3.3 UK
      • 9.3.3.1 Rising geriatric population and increasing demand for oral hygiene products to encourage market growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Persistent burden of dental diseases and favorable government initiatives to spur market growth
    • 9.3.5 ITALY
      • 9.3.5.1 Aging demographic and prevalence of chronic dental diseases to aid market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Strong dental care infrastructure and high focus on quality healthcare to support market growth
    • 9.3.7 SWITZERLAND
      • 9.3.7.1 Focus on high standard of living to drive popularity of advanced oral hygiene products
    • 9.3.8 POLAND
      • 9.3.8.1 Strong public healthcare system and wider access to high-quality dental care products to propel market growth
    • 9.3.9 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Focus on oral hygiene and high burden of age-related dental conditions to fuel demand for preventive oral care products
    • 9.4.3 JAPAN
      • 9.4.3.1 Strong dental health awareness and presence of key players to augment market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing awareness about dental health and growing consumer purchasing power to support market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Favorable government initiatives and high incidence of dental diseases to accelerate market growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising disposable income and increasing demand for advanced dental care solutions to favor market growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 High rate of urbanization to sustain demand for quality oral care products
    • 9.5.3 MEXICO
      • 9.5.3.1 Easy access to modern dental clinics, pharmacies, and e-commerce platforms to aid market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 EASY AVAILABILITY OF ORAL CARE PRODUCTS THROUGH URBAN CONVENIENCE STORES AND E-COMMERCE TO DRIVE MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 INCREASING DEMAND FOR ADAVNCED DENTAL CARE SERVICES TO AUGMENT MARKET GROWTH
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORAL RINSES MARKET
  • 10.3 REVENUE ANALYSIS, 2020-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product type footprint
      • 10.5.5.4 Indication footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 R&D EXPENDITURE OF KEY PLAYERS
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES
    • 10.10.2 DEALS
    • 10.10.3 EXPANSIONS
    • 10.10.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 KENVUE
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches
        • 11.1.1.3.2 Deals
        • 11.1.1.3.3 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 COLGATE-PALMOLIVE COMPANY
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Other developments
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 PROCTER & GAMBLE
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 HALEON GROUP OF COMPANIES
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches
        • 11.1.4.3.2 Deals
        • 11.1.4.3.3 Expansions
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 UNILEVER
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 CHURCH & DWIGHT CO., INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches
        • 11.1.6.3.2 Deals
    • 11.1.7 LION CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches
        • 11.1.7.3.2 Deals
        • 11.1.7.3.3 Expansions
    • 11.1.8 AMWAY CORP.
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
    • 11.1.9 SUNSTAR SUISSE S.A.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches
    • 11.1.10 PERRIGO COMPANY PLC
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
    • 11.1.11 DABUR
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Deals
    • 11.1.12 HIMALAYA WELLNESS COMPANY
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 KAO CORPORATION
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
    • 11.1.14 OPELLA HEALTHCARE GROUP SAS
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Deals
    • 11.1.15 SMARTMOUTH ORAL HEALTH LABORATORIES
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches
  • 11.2 OTHER PLAYERS
    • 11.2.1 DENTAID
    • 11.2.2 CLOSYS
    • 11.2.3 SCANDERRA GMBH
    • 11.2.4 PEARLIE WHITE
    • 11.2.5 WILD
    • 11.2.6 BOKA
    • 11.2.7 PERFORA
    • 11.2.8 SALT ORAL CARE
    • 11.2.9 ORABIO
    • 11.2.10 LUMINEUX

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ORAL RINSES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 ORAL RINSES MARKET: STUDY ASSUMPTIONS
  • TABLE 4 ORAL RINSES MARKET: RISK ANALYSIS
  • TABLE 5 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 6 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022-2024 (USD)
  • TABLE 7 ORAL RINSES MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 ORAL RINSES MARKET: PORTER'S FIVE FORCES
  • TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
  • TABLE 10 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS
  • TABLE 11 IMPORT DATA FOR HS CODE 330690, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 12 EXPORT DATA FOR HS CODE 330690, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ORAL RINSES MARKET: LIST OF MAJOR PATENTS, 2022-2024
  • TABLE 19 ORAL RINSES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 20 ORAL RINSES MARKET: UNMET NEEDS
  • TABLE 21 ORAL RINSES MARKET: END-USER EXPECTATIONS
  • TABLE 22 CASE STUDY 1: CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE CHEMOTHERAPY-INDUCED ORAL MUCOSITIS
  • TABLE 23 CASE STUDY 2: ANTISPETIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS
  • TABLE 24 CASE STUDY 3: HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS
  • TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 26 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ORAL CARE PRODUCTS
  • TABLE 27 ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 28 ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (MILLION UNITS)
  • TABLE 29 THERAPEUTIC ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 COSMETIC ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 OTHER ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 33 ORAL RINSES MARKET FOR GENERAL ORAL HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 ORAL RINSES MARKET FOR GINGIVITIS & PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 ORAL RINSES MARKET FOR HALITOSIS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 ORAL RINSES MARKET FOR DRY MOUTH, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 ORAL RINSES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 39 ORAL RINSES MARKET FOR CONSUMER STORES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 ORAL RINSES MARKET FOR RETAIL PHARMACIES & DENTAL DISPENSARIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ORAL RINSES MARKET FOR ONLINE DISTRIBUTION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 ORAL RINSES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 NORTH AMERICA: ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 47 US: KEY MACROINDICATORS
  • TABLE 48 US: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 49 US: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 50 US: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 51 CANADA: KEY MACROINDICATORS
  • TABLE 52 CANADA: ORAL RINSES MARKET, BY PRODUCT TYPE , 2023-2030 (USD MILLION)
  • TABLE 53 CANADA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 54 CANADA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 55 EUROPE: ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 57 EUROPE: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 58 EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 59 GERMANY: KEY MACROINDICATORS
  • TABLE 60 GERMANY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 61 GERMANY: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 62 GERMANY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 63 UK: KEY MACROINDICATORS
  • TABLE 64 UK: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 UK: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 66 UK: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 67 FRANCE: KEY MACROINDICATORS
  • TABLE 68 FRANCE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 FRANCE: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 70 FRANCE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 71 ITALY: KEY MACROINDICATORS
  • TABLE 72 ITALY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 ITALY: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 74 ITALY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 75 SPAIN: KEY MACROINDICATORS
  • TABLE 76 SPAIN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 SPAIN: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 78 SPAIN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 79 SWITZERLAND: KEY MACROINDICATORS
  • TABLE 80 SWITZERLAND: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 81 SWITZERLAND: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 82 SWITZERLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 83 POLAND: KEY MACROINDICATORS
  • TABLE 84 POLAND: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 85 POLAND: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 86 POLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 87 REST OF EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 REST OF EUROPE: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 89 REST OF EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 94 CHINA: KEY MACROINDICATORS
  • TABLE 95 CHINA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 CHINA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 97 CHINA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 98 JAPAN: KEY MACROINDICATORS
  • TABLE 99 JAPAN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 JAPAN: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 101 JAPAN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 102 INDIA: KEY MACROINDICATORS
  • TABLE 103 INDIA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 INDIA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 105 INDIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 106 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 107 AUSTRALIA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 AUSTRALIA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 109 AUSTRALIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 110 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 111 SOUTH KOREA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 SOUTH KOREA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 113 SOUTH KOREA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 114 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 116 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: ORAL RINSES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 119 LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 120 LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 121 BRAZIL: KEY MACROINDICATORS
  • TABLE 122 BRAZIL: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 BRAZIL: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 124 BRAZIL: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 125 MEXICO: KEY MACROINDICATORS
  • TABLE 126 MEXICO: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 127 MEXICO: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 128 MEXICO: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 129 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 131 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 134 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: ORAL RINSES MARKET, BY INDICATION, 2023-2030 (USD MILLION)
  • TABLE 137 GCC COUNTRIES: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
  • TABLE 138 MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN ORAL RINSES MARKET, JANUARY 2022-JUNE 2025
  • TABLE 139 ORLA RINSES MARKET: DEGREE OF COMPETITION
  • TABLE 140 ORAL RINSES MARKET: REGION FOOTPRINT
  • TABLE 141 ORAL RINSES MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 142 ORAL RINSES MARKET: INDICATION FOOTPRINT
  • TABLE 143 ORAL RINSES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 144 ORAL RINSES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION
  • TABLE 145 ORAL RINSES MARKET: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 146 ORAL RINSES MARKET: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 147 ORAL RINSES MARKET: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 148 ORAL RINSES MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
  • TABLE 149 KENVUE: COMPANY OVERVIEW
  • TABLE 150 KENVUE: PRODUCTS OFFERED
  • TABLE 151 KENVUE: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 152 KENVUE: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 153 KENVUE: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 154 COLGATE-PALMOLIVE COMPANY: COMPANY OVERVIEW
  • TABLE 155 COLGATE-PALMOLIVE COMPANY: PRODUCTS OFFERED
  • TABLE 156 COLGATE-PALMOLIVE COMPANY: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 157 COLGATE-PALMOLIVE COMPANY: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 158 COLGATE-PALMOLIVE COMPANY: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
  • TABLE 159 PROCTER & GAMBLE: COMPANY OVERVIEW
  • TABLE 160 PROCTER & GAMBLE: PRODUCTS OFFERED
  • TABLE 161 PROCTER & GAMBLE: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 162 PROCTER & GAMBLE: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 163 HALEON GROUP OF COMPANIES: COMPANY OVERVIEW
  • TABLE 164 HALEON GROUP OF COMPANIES: PRODUCTS OFFERED
  • TABLE 165 HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 166 HALEON GROUP OF COMPANIES: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 167 HALEON GROUP OF COMPANIES: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 168 UNILEVER: COMPANY OVERVIEW
  • TABLE 169 UNILEVER: PRODUCTS OFFERED
  • TABLE 170 UNILEVER: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 171 CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW
  • TABLE 172 CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED
  • TABLE 173 CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 174 CHURCH & DWIGHT CO., INC.: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 175 LION CORPORATION: COMPANY OVERVIEW
  • TABLE 176 LION CORPORATION: PRODUCTS OFFERED
  • TABLE 177 LION CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 178 LION CORPORATION: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 179 LION CORPORATION: EXPANSIONS, JANUARY 2022-JUNE 2025
  • TABLE 180 AMWAY CORP.: COMPANY OVERVIEW
  • TABLE 181 AMWAY CORP.: PRODUCTS OFFERED
  • TABLE 182 SUNSTAR SUISSE S.A.: COMPANY OVERVIEW
  • TABLE 183 SUNSTAR SUISSE S.A.: PRODUCTS OFFERED
  • TABLE 184 SUNSTAR SUISSE S.A.: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 185 PERRIGO COMPANY PLC: COMPANY OVERVIEW
  • TABLE 186 PERRIGO COMPANY PLC: PRODUCTS OFFERED
  • TABLE 187 PERRIGO COMPANY PLC: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 188 DABUR: COMPANY OVERVIEW
  • TABLE 189 DABUR: PRODUCTS OFFERED
  • TABLE 190 DABUR: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 191 HIMALAYA WELLNESS COMPANY: COMPANY OVERVIEW
  • TABLE 192 HIMALAYA WELLNESS COMPANY: PRODUCTS OFFERED
  • TABLE 193 KAO CORPORATION: COMPANY OVERVIEW
  • TABLE 194 KAO CORPORATION: PRODUCTS OFFERED
  • TABLE 195 OPELLA HEALTHCARE GROUP SAS: COMPANY OVERVIEW
  • TABLE 196 OPELLA HEALTHCARE GROUP SAS: PRODUCTS OFFERED
  • TABLE 197 OPELLA HEALTHCARE GROUP SAS: DEALS, JANUARY 2022-JUNE 2025
  • TABLE 198 SMARTMOUTH ORAL HEALTH LABORATORIES: COMPANY OVERVIEW
  • TABLE 199 SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCTS OFFERED
  • TABLE 200 SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
  • TABLE 201 DENTAID: COMPANY OVERVIEW
  • TABLE 202 CLOSYS: COMPANY OVERVIEW
  • TABLE 203 SCANDERRA GMBH: COMPANY OVERVIEW
  • TABLE 204 PEARLIE WHITE: COMPANY OVERVIEW
  • TABLE 205 WILD: COMPANY OVERVIEW
  • TABLE 206 BOKA: COMPANY OVERVIEW
  • TABLE 207 PERFORA: COMPANY OVERVIEW
  • TABLE 208 SALT ORAL CARE: COMPANY OVERVIEW
  • TABLE 209 ORABIO: COMPANY OVERVIEW
  • TABLE 210 LUMINEUX: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 ORAL RINSES MARKET: YEARS CONSIDERED
  • FIGURE 3 ORAL RINSES MARKET: RESEARCH DESIGN
  • FIGURE 4 ORAL RINSES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 ORAL RINSES MARKET: KEY PRIMARY DATA SOURCES
  • FIGURE 6 ORAL RINSES MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 ORAL RINSES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 ORAL RINSES SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 11 REVENUE SHARE ANALYSIS FOR HALEON GROUP OF COMPANIES (2024)
  • FIGURE 12 ORAL RINSES MARKET: SUPPLY-SIDE ANALYSIS (2024)
  • FIGURE 13 ORAL RINSES MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
  • FIGURE 14 ORAL RINSES MARKET: BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS)
  • FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
  • FIGURE 16 ORAL RINSES MARKET: TOP-DOWN APPROACH
  • FIGURE 17 ORAL RINSES MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 20 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 ORAL RINSES MARKET: REGIONAL SNAPSHOT
  • FIGURE 22 RISING AWARENESS OF PREVENTIVE DENTAL CARE AND ORAL HYGIENE TO DRIVE MARKET
  • FIGURE 23 JAPAN AND THERAPEUTIC RINSES ACCOUNTED FOR LARGEST ASIA PACIFIC ORAL RINSES MARKET SHARE IN 2024
  • FIGURE 24 INDIA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 25 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES FROM 2025 TO 2030
  • FIGURE 27 ORAL RINSES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 ORAL RINSES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 ORAL RINSES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 ORAL RINSES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
  • FIGURE 32 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS
  • FIGURE 33 ORAL RINSES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 34 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR ORAL RINSES MARKET (JANUARY 2014-DECEMBER 2024)
  • FIGURE 35 TOP PATENT APPLICANT COUNTRIES FOR ORAL RINSES MARKET (JANUARY 2014-DECEMBER 2024)
  • FIGURE 36 MARKETS ADJACENT TO ORAL RINSES MARKET
  • FIGURE 37 ORAL RINSES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 38 ORAL RINSES MARKET: FUNDING AND NUMBER OF DEALS, 2019-2023
  • FIGURE 39 ORAL RINSES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 40 NORTH AMERICA: ORAL RINSES MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: ORAL RINSES MARKET SNAPSHOT
  • FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES MARKET (2020-2024)
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES MARKET (2024)
  • FIGURE 44 ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 ORAL RINSES MARKET: COMPANY FOOTPRINT
  • FIGURE 46 ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 ORAL RINSES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 ORAL RINSES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022-2024)
  • FIGURE 51 KENVUE: COMPANY SNAPSHOT
  • FIGURE 52 COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT
  • FIGURE 53 PROCTER & GAMBLE: COMPANY SNAPSHOT
  • FIGURE 54 HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT
  • FIGURE 55 UNILEVER: COMPANY SNAPSHOT
  • FIGURE 56 CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
  • FIGURE 57 LION CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 AMWAY CORP.: COMPANY SNAPSHOT
  • FIGURE 59 SUNSTAR SUISSE S.A.: COMPANY SNAPSHOT
  • FIGURE 60 PERRIGO COMPANY PLC: COMPANY SNAPSHOT
  • FIGURE 61 DABUR: COMPANY SNAPSHOT
  • FIGURE 62 KAO CORPORATION: COMPANY SNAPSHOT